Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption

被引：0
|
作者：
Steven G. Allen
Chao Zhang
Shawn Malone
Soumyajit Roy
Robert T. Dess
William C. Jackson
Rohit Mehra
Corey Speers
Arul M. Chinnaiyan
Yilun Sun
Daniel E. Spratt
机构：
[1] University of Michigan,Department of Radiation Oncology
[2] Ottawa Hospital Research Institute,Department of Radiation Oncology, The Ottawa Hospital Cancer Center
[3] University of Michigan,Department of Pathology
[4] Case Western Reserve University,Department of Radiation Oncology, UH Seidman Cancer Center
[5] University of Michigan,Rogel Cancer Center and Michigan Center for Translational Pathology
[6] Case Western Reserve University,Department of Population Quantitative Health Sciences
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Prostate cancer; Androgen receptor; Adjuvant hormone therapy; Radiotherapy; Homologous recombination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3877 / 3887
页数：10
相关论文
共 50 条
  • [21] Imaging Androgen Receptor Signaling in Prostate Cancer with PET
    Evans, Michael
    Ulmert, David
    Holland, Jason
    Doran, Michael
    Spratt, Daniel
    Sawyers, Charles
    Lewis, Jason
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [22] Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
    Hussein, Mohamed Ali
    Munirathinam, Gnanasekar
    CANCERS, 2023, 15 (20)
  • [23] Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer
    Li, Jing
    Cao, Bo
    Liu, Xichun
    Fu, Xueqi
    Xiong, Zhenggang
    Chen, Li
    Sartor, Oliver
    Dong, Yan
    Zhang, Haitao
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) : 1346 - 1356
  • [24] Epigenetic regulation of androgen receptor signaling in prostate cancer
    Gao, Lina
    Alumkal, Joshi
    EPIGENETICS, 2010, 5 (02) : 100 - 104
  • [25] Inhibition of androgen receptor and β-catenin activity in prostate cancer
    Lee, Eugine
    Madar, Aviv
    David, Gregory
    Garabedian, Michael J.
    DasGupta, Ramanuj
    Logan, Susan K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (39) : 15710 - 15715
  • [26] Extracellular Vesicles in the Adaptive Process of Prostate Cancer during Inhibition of Androgen Receptor Signaling by Enzalutamide
    Soekmadji, Carolina
    Rockstroh, Anja
    Ramm, Grant A.
    Nelson, Colleen C.
    Russell, Pamela J.
    PROTEOMICS, 2017, 17 (23-24)
  • [27] Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling
    Liu, Ningning
    Guo, Zhiqiang
    Xia, Xiaohong
    Liao, Yuning
    Zhang, Fangcheng
    Huang, Chuyi
    Liu, Yuan
    Deng, Xiumei
    Jiang, Lili
    Wang, Xuejun
    Liu, Jinbao
    Huang, Hongbiao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 846 : 1 - 11
  • [28] Novel Therapeutic Strategies for Castration Resistant Prostate Cancer: Inhibition of Persistent Androgen Production and Androgen Receptor Mediated Signaling
    Molina, Arturo
    Belldegrun, Arie
    JOURNAL OF UROLOGY, 2011, 185 (03): : 787 - 794
  • [29] Androgen synthesis disruption, ferroptosis induction and prostate cancer inhibition by androgen and vitamin D combination
    Park, Bobae
    Vaquiz, Jacqueline
    Igbekoyi, Okunola
    Chatterjee, Bandana
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Targeting the androgen receptor signaling pathway in advanced prostate cancer
    Chung, Clement
    Abboud, Karen
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (15) : 1224 - 1235
12345